Skip to content

Equity

BME

Health Sciences Trust

Overview

Loading

Performance

Performance

  • Returns

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.


Returns are shown net of advisory fees paid by the fund and net of the fund’s operating fees and expenses. Investors who purchase shares of the fund through an investment adviser or other financial professional may separately pay a fee to that service provider. Past performance is not indicative of future results.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted, and numbers may reflect small variances due to rounding. Standardized performance and performance data current to the most recent month end may be found in the Performance section.

Growth of Hypothetical $10,000 The growth of hypothetical $10,000 chart reflects a hypothetical $10,000 investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted.

Performance chart data not available for display.
View full chart

Distributions

Interactive chart displaying fund performance. Javascript is required.

View full chart

Key Facts

Key Facts

Net Assets as of Sep 13, 2019 $398,536,984
Managed Assets as of Sep 13, 2019 $398,536,984.39
Share Class launch date Mar 31, 2005
Exchange New York Stock Exchange Inc.
Asset Class Equity
Morningstar Category Health
Lipper Classification Sector Equity Funds
CUSIP 09250W107
Management Fee 1.00%
Gross Expense Ratio 1.11%
Shares Outstanding as of Sep 13, 2019 10,612,765
Number of Holdings as of Aug 30, 2019 98

Ratings

Ratings

Morningstar Rating

5
Overall Morningstar Rating for Health Sciences Trust, -, as of Aug 31, 2019 rated against 6 Health Funds.

Holdings

Holdings

as of Aug 30, 2019
Name Weight (%)
UNITEDHEALTH GROUP INC 7.51
ABBOTT LABORATORIES 6.62
BOSTON SCIENTIFIC CORPORATION 4.15
STRYKER CORPORATION 3.74
THERMO FISHER SCIENTIFIC INC 3.63
Name Weight (%)
MEDTRONIC PLC 3.56
MERCK & CO INC 3.26
AMGEN INC 2.99
EDWARDS LIFESCIENCES CORP 2.84
ZOETIS INC 2.76

Exposure Breakdowns

Exposure Breakdowns

as of Aug 30, 2019

% of Market Value Based on Managed Assets

Type Fund
as of Aug 30, 2019

% of Market Value Based on Managed Assets

Type Fund
as of Aug 30, 2019

% of Market Value Based on Managed Assets

Type Fund
as of Aug 30, 2019

% of Market Value Based on Managed Assets

Type Fund
Negative weightings may result from specific circumstances (including timing differences between trade and settle dates of securities purchased by the funds) and/or the use of certain financial instruments, including derivatives, which may be used to gain or reduce market exposure and/or risk management.

Allocations are subject to change.

Portfolio Managers

Portfolio Managers

Erin Xie
Head of the Health Sciences team

  

Kyle McClements
Kyle McClements
Christopher Accettella
Christopher Accettella
Portfolio Manager

Literature

Literature